Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes
Clinical trial NCT02680795 · COMPLETED
Trial details
- NCT number
- NCT02680795
- Sponsor
- Acrotech Biopharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-27
- Primary completion
- 2020-07-21
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.